JFCR39, a panel of 39 human cancer cell lines, and its application in the discovery and development of anticancer drugs
- PMID: 22336246
- DOI: 10.1016/j.bmc.2012.01.017
JFCR39, a panel of 39 human cancer cell lines, and its application in the discovery and development of anticancer drugs
Abstract
Over the past few decades, panels of human cancer cell lines have made a significant contribution to the discovery and development of anticancer drugs. The National Cancer Institute 60 (NCI60), which consists of 60 cell lines from various human cancer types, remains the most powerful human cancer cell line panel for high throughput screening of anticancer drugs. The development of JFCR39, comprising a panel of 39 human cancer cell lines coupled with a drug-activity database, was based on NCI60. Like NCI60, JFCR39 not only provides disease-oriented information but can also predict the action mechanism or molecular target of a given antitumor agent by utilizing the COMPARE algorithm. The molecular targets of ZSTK474 as well as several other antitumor agents have been identified by using JFCR39 and some of these compounds have since entered clinical trials. In this review, we will describe human cancer cell line panels particularly JFCR39 and its application in the discovery and/or development of anticancer drug candidates.
Copyright © 2012 Elsevier Ltd. All rights reserved.
Similar articles
-
Evaluation of action mechanisms of toxic chemicals using JFCR39, a panel of human cancer cell lines.Mol Pharmacol. 2007 Nov;72(5):1171-80. doi: 10.1124/mol.107.038836. Epub 2007 Aug 16. Mol Pharmacol. 2007. PMID: 17702889
-
Panel of human cancer cell lines provides valuable database for drug discovery and bioinformatics.Cancer Chemother Pharmacol. 2003 Jul;52 Suppl 1:S74-9. doi: 10.1007/s00280-003-0649-1. Epub 2003 Jun 18. Cancer Chemother Pharmacol. 2003. PMID: 12819939 Review.
-
ZSTK474, a novel phosphatidylinositol 3-kinase inhibitor identified using the JFCR39 drug discovery system.Acta Pharmacol Sin. 2010 Sep;31(9):1189-97. doi: 10.1038/aps.2010.150. Epub 2010 Aug 23. Acta Pharmacol Sin. 2010. PMID: 20729870 Free PMC article. Review.
-
[Chemical evaluation by cancer cell line panel and its role in molecular target-based anticancer drug screening].Gan To Kagaku Ryoho. 2004 Apr;31(4):485-90. Gan To Kagaku Ryoho. 2004. PMID: 15114687 Japanese.
-
Isoindolo[2,1-c]benzo[1,2,4]triazines: a new ring system with antiproliferative activity.Bioorg Med Chem. 2007 Jan 1;15(1):343-9. doi: 10.1016/j.bmc.2006.09.054. Epub 2006 Sep 29. Bioorg Med Chem. 2007. PMID: 17064918
Cited by
-
Structural Modifications of Nature-Inspired Indoloquinolines: A Mini Review of Their Potential Antiproliferative Activity.Molecules. 2019 Jun 5;24(11):2121. doi: 10.3390/molecules24112121. Molecules. 2019. PMID: 31195640 Free PMC article. Review.
-
Cancer Cell Line Panels Empower Genomics-Based Discovery of Precision Cancer Medicine.Yonsei Med J. 2015 Sep;56(5):1186-98. doi: 10.3349/ymj.2015.56.5.1186. Yonsei Med J. 2015. PMID: 26256959 Free PMC article. Review.
-
A novel pan-PI3K inhibitor KTC1101 synergizes with anti-PD-1 therapy by targeting tumor suppression and immune activation.Mol Cancer. 2024 Mar 14;23(1):54. doi: 10.1186/s12943-024-01978-0. Mol Cancer. 2024. PMID: 38486218 Free PMC article.
-
Conformation-activity relationships of polyketide natural products.Nat Prod Rep. 2015 Aug;32(8):1183-206. doi: 10.1039/c5np00014a. Nat Prod Rep. 2015. PMID: 25974024 Free PMC article. Review.
-
In vitro antitumor activity of stellettin B, a triterpene from marine sponge Jaspis stellifera, on human glioblastoma cancer SF295 cells.Mar Drugs. 2014 Jul 15;12(7):4200-13. doi: 10.3390/md12074200. Mar Drugs. 2014. PMID: 25028795 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Chemical Information
Research Materials
Miscellaneous
